<?xml version="1.0" encoding="UTF-8"?>
<BillSummaries>
<item congress="114" measure-type="hr" measure-number="971" measure-id="id114hr971" originChamber="HOUSE" orig-publish-date="2015-02-13" update-date="2015-07-07">
<title>Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015</title>
<summary summary-id="id114hr971v00" currentChamber="HOUSE" update-date="2015-07-07">
<action-date>2015-02-13</action-date>
<action-desc>Introduced in House</action-desc>
<summary-text><![CDATA[<p><b>Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015</b></p> <p>Amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to extend by six months the exclusivity period for an approved drug or biological product when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition (also known as an &ldquo;orphan disease&rdquo;).</p> <p>Allows the FDA to revoke an extension if the application for the new indication contained an untrue material statement.</p> <p>Requires the sponsor of a product receiving an extension to notify the FDA one year prior to discontinuing production for commercial reasons.</p> <p>Requires the FDA to notify the public of products that receive this extension and patents related to those products.</p> <p>Limits a product to one extension under this Act. Sets forth that extensions under this Act are in addition to other extensions.</p> Applies only to products approved after enactment of this Act for a new indication that is a rare disease or condition.]]></summary-text>
</summary>
</item>
<dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
<dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
<dc:description>This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
</dublinCore>
</BillSummaries>
